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A central problem in biology is to identify gene
function. One approach is to infer function in large
supergenomic networks of interactions and ances-
tral relationships among genes; however, their anal-
ysis can be computationally prohibitive. We show
here that these biological networks are compress-
ible. They can be shrunk dramatically by elimi-
nating redundant evolutionary relationships, and
this process is efficient because in these networks
the number of compressible elements rises linearly
rather than exponentially as in other complex
networks. Compression enables global network
analysis to computationally harness hundreds of
interconnected genomes and to produce functional
predictions. As a demonstration, we show that
the essential, but functionally uncharacterized Plas-
modium falciparum antigen EXP1 is a membrane
glutathione S-transferase. EXP1 efficiently degrades
cytotoxic hematin, is potently inhibited by artesu-
nate, and is associated with artesunate metabolism
and susceptibility in drug-pressured malaria para-
sites. These data implicate EXP1 in the mode of ac-
tion of a frontline antimalarial drug.916 Cell 158, 916–928, August 14, 2014 ª2014 Elsevier Inc.INTRODUCTION
The biological functions of most genes are unknown (Erdin
et al., 2011) and therefore require novel methods of identifica-
tion (Radivojac et al., 2013). Increasingly, these methods rely
on computational network analysis (Sharan et al., 2007).
Such networks are composed of protein or gene nodes con-
nected by intrinsic links, which indicate common evolutionary
origins across species, and contextual links, which indicate in-
teractions or biological correlations among genes and proteins
within a genome. The function of a protein node can then be
inferred either through local network analysis that transfers
annotations from the nodes it directly connects to or through
global analysis that optimizes some relatedness measure
over the entire network (Sharan et al., 2007; Vazquez et al.,
2003). Although local network analyses are computationally
relatively inexpensive, they are also of limited value in sparsely
annotated network regions (Erdin et al., 2011) because they
cannot reach for information beyond an immediate neighbor-
hood (Chua et al., 2006). Unfortunately, such areas of very
sparsely annotated genome regions include genomes of dis-
ease-causing agents (Ideker and Sharan, 2008). For example,
in the human malarial parasite Plasmodium falciparum, the
low sensitivity of current annotation methods leaves most
genes without any known biological function (Aurrecoechea
et al., 2009; Gardner et al., 2002). By contrast, global network
approaches can be more sensitive, but their computational
demands typically restrict them to smaller networks that can
encompass single proteomes with only several thousand no-
des (Erdin et al., 2011; Vazquez et al., 2003).
In this study, we apply a known global network-based func-
tion prediction method, termed graph-based information diffu-
sion (GID; Venner et al., 2010), over so-called supergenomic
networks that comprise all the genes from hundreds of ge-
nomes. To achieve this, we propose a general network
compression scheme that dramatically reduces the number of
network links by eliminating redundancies within and between
network cliques. In the context of supergenomic networks,
these cliques consist of clusters of orthologous groups of pro-
teins (COGs) (Tatusov et al., 1997). Critically, network compres-
sion does not significantly perturb global network analysis: GID
is much more efficient on a compressed network but still accu-
rately reproduces GID outputs on an uncompressed network.
Thus network compression opens, in principle, the known
gene and protein space to global network-based function
prediction.
As a validation of this approach, we tested a GID-based pre-
diction in P. falciparum 3D7 parasites of the biological function
of exported protein 1 (EXP1), also referred to as exported an-
tigen 5.1 (Ag5.1) or circumsporozoite-related antigen/protein
(CRA) (Hope et al., 1984; Simmons et al., 1987). Even though
the biological role of EXP1 has not been characterized, several
lines of evidence suggest that this small 17 kDa polypeptide is
important to malaria pathogenesis. Failure to disrupt this exp1
gene, which is well conserved among Plasmodium species
(Simmons et al., 1987), suggests its essentiality for the para-
site (Maier et al., 2008). This gene is also one of the most
abundantly transcribed loci (PF11_0224/PF3D7_1121600) dur-
ing the ring and early trophozoite stages (Bozdech et al., 2003;
Le Roch et al., 2004), which is the asexual parasite’s initial
growth phase in erythrocytes. The protein product is mainly
exported to the parasitophorous vacuolar membrane (PVM)
and to cytosolic compartments in infected red blood cells
(RBCs) (Simmons et al., 1987), where it forms homomers in
the membrane (Spielmann et al., 2006). EXP1 triggers an anti-
genic immune response in humans (Simossis et al., 2005) and
has been explored as a malaria vaccine candidate (Caspers
et al., 1991; Meraldi et al., 2004). We demonstrate, as pre-
dicted by GID, that EXP1 is a glutathione S-transferase
(GST) that conjugates glutathione onto hematin—the main
cytotoxin released during malarial blood stage infection. This
activity is unique among known membrane GSTs but is none-
theless consistent with their ability to protect cells against
xenobiotic and oxidative stress (Morgenstern et al., 2011).
We further show that EXP1 is potently inhibited by the cur-
rent antimalarial drug of choice, artesunate (ART). This solu-
ble artemisinin derivative is currently recommended by the
World Health Organization as the frontline treatment of
severe falciparum malaria (World Health Organization (WHO),
2011) even though its future efficacy is uncertain due to
emerging parasite resistance to artemisinins (Ariey et al.,
2014). Our identification of EXP1 as a P. falciparum mem-
brane-bound GST suggests previously unresolved modes of
hematin metabolism and ART-mediated stress response in
parasitized RBCs.RESULTS
Supergenomic Networks of Evolutionary Relationships
Are Compressible
Network compression exploits the COG cliques present in
supergenomic networks (see Experimental Procedures) in two
steps. First, intra-clique compression replaces each COG clique
with a star graph (Figure 1A). All the edges among the members
of a clique are removed, and instead every node becomes
connected by a single edge to a new core node for the clique,
weighted by the size of the clique, ncog (Figures 1A and 1B). In
a realistic supergenomic network, however, still more compres-
sion is required. For example, over 373 proteomes from different
species, the STRING (Search Tool for the Retrieval of Interacting
Genes/Proteins) database (von Mering et al., 2007), yielded
a supergenomic network with nz1.513 106 protein nodes con-
nected by ncz3.863 10
7 contextual links and up to niz1.933
1011 intrinsic links (Figure 1B and Experimental Procedures).
The latter included 5.41 3 108 intra-COG links from 33,929
COGs. Intra-clique compression reduces these nearly 400-
fold, to 1.38 3 106, at the cost of adding 2% (33,929) new
core nodes to build the star graphs. The network structure, how-
ever, is still dominated by 1011 inter-COG links and remains
beyond practical computational capabilities.
To further reduce computational cost, the second essential
step is inter-clique compression, which additionally compresses
evolutionary relationships between COGs. All the links between
a pair of COGs are replaced by a single edge connecting
their core nodes, weighted by average sequence similarity
between COGs (Figure 1C). The number of inter-COG links
now falls almost 105-fold from 1.93 3 1011 to 6.81 3 106. After
full compression, the total number of remaining intrinsic links is
8.19 3 106, which is of the same order of magnitude as that of
contextual links.
Critically, this compression perturbs GID only mildly: in exten-
sive simulations on random networks with nodes assigned
random initial conditions, the relative error between GID on the
full network and on the compressed network remained below
10%when the original uncompressed graph had an edge den-
sity below 20% (Figures S1A and S1B; see specific example
in Figures 1D and 1E), i.e., when the graph contained less than
20% of all possible edges (see Extended Experimental Proce-
dures). Thus network compression perturbs GID minimally when
the underlying network is sparse. These and additional numerical
data (Figures S1C–S1E and Extended Experimental Procedures)
suggest that network compression was essential to practically
enable GID on large supergenomic networks with a loss of accu-
racy that is tolerable and adjustable.
Theoretical Reason for Compressibility
Network compression was computationally efficient because
in supergenomic networks, the number of maximal cliques has
a linear relation to the number of network nodes (Figure S1F).
Given that the computational time to find all maximal cliques in
a network is bounded linearly by the number of nodes per single
maximal clique (Eppstein et al., 2010), the observation that the
total maximal clique number rises linearly and not exponentially
with network size ensures that a complete list of compressible
cliques can be computed efficiently, i.e., in nonexponential,Cell 158, 916–928, August 14, 2014 ª2014 Elsevier Inc. 917
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Figure 1. Compression of Supergenomic
Networks
(A) Supergenomic network with multiple genomes/
proteomes (gray ovals) and links depicting intrinsic
and contextual gene associations.
(B) COG cliques of size ncog are transformed in
intra-COG compression into weighted star graphs.
For both cliques and star graphs, every node is
connected to the new node with a link of weight w,
and the resulting link weight at each clique or star
graph member is w ncog.
(C) Inter-COG compression additionally replaces
all sequence similarity links between members in
two different COGs with a single link. Contextual
links are not compressed.
(D) Intra-clique network compression example of
an n = 1,000 node network with six cliques. The
edge density, i.e., the ratio of the actual number of
edges over the maximum edge number n(n  1)/2,
of the uncompressed network is 0.013, and the
compressed network has only one-third the num-
ber of links from the original network.
(E) GID output comparison in logarithmic scale
between the full, uncompressed, and compressed
networks as shown in (D). GID input labeling in the
first third of indexed nodes was ‘‘1,’’ second was
‘‘0,’’ and third was ‘‘+1’’ (gray curve). The GID
output is shown in red, and the absolute error
(vector norm difference between uncompressed
and compressed GID output) in yellow. Despite the
loss of more than 60% of its links, the GID output
on the compressed networks had only 0.4%
average relative error, defined as the absolute error
divided by the vector norm of the GID output of the
uncompressed network. Due to the logarithmic
scale, negative class label values are represented
in absolute values.linear time (Figure S1G, black graph). In contrast, other common
complex networks such as Erd}os-Re´nyi random graphs have a
number of maximal cliques that are exponential in the number
of nodes (Figure S1G, red graph). Consequently, in larger net-
works, their detection quickly becomes computationally prohib-
itive. Supergenomic networks are therefore biological examples
of networks where clique detection is computationally efficient.
To explain the efficiency of compression in supergenomic net-
works, wemodeled evolutionary relationships between genes by
preferential attachment among cliques (Figure S1H): beginning
with a small number of a few given cliques, a new clique was
added to the network by linking it to an existing clique with
a probability defined by the connectivity of that clique. This
scale-free network generation model (Wang et al., 2009) is a nat-
ural generalization of both Yule’s model of biological speciation
(Yule, 1925) and the Barabasi-Albert model of preferential
attachment for scale-free networks (Barabasi and Albert, 1999;918 Cell 158, 916–928, August 14, 2014 ª2014 Elsevier Inc.Newman, 2005). It predicts that for large
clique sizes k >> 1, their distribution
follows a power law k g with g = 3.
In agreement with this prediction, we
measured g = 2.94 ± 0.03 for the clique
(COG) sizes in the supergenomic network(Figure S1I), which implies that its structure was consistent
with preferential attachment. Because preferential attachment
necessarily produces scale-free networks, in which all maximal
cliques can be localized efficiently in computer time that scales
linearly with network size (Eppstein et al., 2010), the model offers
a rationale for the compressibility of supergenomic networks.
Functional Matching on Compressed Supergenomic
Networks
In order to benchmark the performance of functional predictions,
we next tested the ability to recover the activities of test proteins
after hiding their Gene Ontology (GO) Molecular Function infor-
mation from the network (leave-one-out experiments). The GID
output was ranked by statistical Z scores. These scores were
insensitive to compression error (Figure 2A) and were based on
a normal approximation for the global distribution of reciprocal
GID output log-ratios (Figure 2B, example in Figure 2C, and
Extended Experimental Procedures). For comparison, we used
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Figure 2. Functional Matching on a Supergenomic Network
(A) Transformation of GID output f scores (absolute values) into output Z scores (red solid line); error in output Z scores due to a given GID compression error in
f scores (dashed black line).
(B) GID output Z scores follow approximately a shifted Gaussian distribution (represented here on a reciprocal log scale). The shift follows from the bias in the
functional input labels to negative values.
(C) Example output for one leave-one-out test (MMP1595, a Methanococcus maripaludis queuine tRNA-ribosyltransferase; EC 2.4.2.29). The histogram shows
the distribution of output Z scores over the entire network, where statistically significant matches are above Z = 2. For a fixed number of 50 false matches, GID is
more sensitive than PSI-BLAST: it detects 307 true positives (TP) against 42 with PSI-BLAST, or ACC50 = 0.86 against ACC50 = 0.45, where ACC50 is the accuracy
defined as TP/(TP + 50). Shown are corresponding histogram of sequence identities to the query sequence and a dendrogram of true matches across species for
PSI-BLAST (black) and GID (red).
(D) Accuracy as a function of minimum Z scores cut-off.
(E) GID versus PSI-BLAST scatter plot of accuracy values for the test set of 1,000 fully annotated (EC numbers) enzyme sequences.
(F and G) GID versus COG (F) and GID versus RankProp (G) scatter plots for the same test set.two local and one global algorithm for sequence similarity net-
works. The local methods were PSI-BLAST sequence search
(Altschul et al., 1997), where all links from the full uncompressed
network were allowed for matching, and the ranking of network
COGs was by their average sequence similarity to the query pro-
tein (COG method). Because neither method takes into account
contextual information, GID was limited to intrinsic evolutionary
links for fair comparison. A set of 1,000 enzymes from the
curated SwissProt collection of the UniProt database (UniProt
Consortium, 2010) defined the test set of the leave-one-out ex-
periments. Over these experiments, we measured success by
the average number of true positive predictions made prior toreaching 50 false predictions, or ACC50 accuracy values (Grib-
skov and Robinson, 1996). We found that GID Z scores above
Z 2 were reliable indicators of functional accuracy (Figure 2D)
giving accuracies that were 9% greater for GID than for PSI-
BLAST (p < 9.2 3 1017, Wilcoxon signed rank test; Figure 2E)
and 21% more than with COGs (p < 1.7 3 1011; Figure 2F).
Our results showed that local algorithms on the full, uncom-
pressed network (such as PSI-BLAST) yielded lower prediction
accuracies than GID on the compressed network.
We also benchmarked GID against an established global algo-
rithm, RankProp (Melvin et al., 2009). The iterative flow algorithm
underlying RankProp was computationally intractable on theCell 158, 916–928, August 14, 2014 ª2014 Elsevier Inc. 919
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Figure 3. Prediction and Experimental Confirmation of EXP1 Function
(A) GID analysis of EXP1 performed for all GO terms that were enriched significantly in the three possible clusters.
(B) GID predictions of molecular function and biological process in Z score histograms for all P. falciparum genes extracted from the network.
(C) Purified EXP1 at apparent molecular weight near 23 kDa, which is higher than the predicted 17 kDa and a known anomaly of this antigen (Hope et al., 1985).
(D) No EXP1 antibody interference with both expression host GST from Escherichia coli and positive control GST from Schistosoma japonicum (SjGST).
(E) GST activity of EXP1 toward CDNB; negative control with bovine serum albumin (BSA). Mean values and standard error bars are from three experimental
results.
(F) Extended homology sequence alignment of P. falciparum EXP1 and Anopheles gambiaemicrosomal glutathione S-transferase GSTMIC3 indicates a putative
shared site (positions 59–89 with 46% similarity, green box); this region includes a charged helical stretch (red bar). Sequence logos from multiple sequence
alignments indicate similar amino acid composition at the putative catalytic residue positions. Secondary structure comparison between EXP1 and GSTMIC3
reveals further commonalities. E-domain indicates putative MGST oligomerization domain (Holm et al., 2006).uncompressed supergenomic network, so RankProp was also
applied to the intrinsic compressed network. In that test (Fig-
ure 2G), GID detected 5% more true matches than RankProp
(p < 1.3 3 103). This further confirmed that compression is an
essential step toward a global analysis of large networks, and
that GID can improve function detection in comparison with
other global methods.
Application to the P. falciparumGenome: TheMolecular
Function of EXP1
EXP1 Enzymatic Function Prediction and Validation
To predict novel molecular functions over many genomes, we
used competitive GID (Venner et al., 2010) on the compressed
supergenomic network: at any tested level of the GO hierarchy,
the most likely molecular function was determined by the GO
termwith the highest significant Z score. Given the prior distribu-
tion of input functional labels (Figure S3A), we produced 92,892
significant predictions (with Z > 2) for 1,889 Molecular Function
enzyme commission (EC) numbers in archaea (4% of predic-
tions), bacteria (48%), and eukaryota (48%; see Table S1). Bacil-
lus anthracis and P. falciparum, causative agents of anthrax and
malaria, had the smallest numbers of genes annotated with GO
Molecular Function terms compared to their total numbers of920 Cell 158, 916–928, August 14, 2014 ª2014 Elsevier Inc.genes in the prokaryotic and eukaryotic categories, respectively
(Figure S3B). This last case confirmed earlier observations
that the majority of the P. falciparum 3D7 genome is difficult to
annotate with biological function (Ochoa et al., 2011). To rank
the importance of gene targets among the 305 P. falciparum
functional predictions made with GID, we reviewed their number
of references in the scientific literature (Table S2). This analysis
highlighted EXP1 as the most cited P. falciparum gene with no
known molecular function and for which we had a functional
prediction.
When applied to EXP1, competitive GID predicted ‘‘catalytic
activity’’ (Z = 2.39) as the only significant term at the highest GO
level. Out of six main enzymatic classes, ‘‘transferase activity’’
(Z = 2.38) most strongly associated with EXP1 (Figures 3A and
3B and Table S2). No prediction from the transferase subclasses
achieved a significant Z score, but three main functional clusters
in eukaryotic integralmembrane transferases emerged: glycosyl-
transferases (EC 2.4.1), protein kinases (EC 2.7), andmicrosomal
glutathione S-transferases (GST, EC 2.5.1.18; Figure 3A). A
search in the GO Biological Process category produced ‘‘gluta-
thione metabolism’’ (Z = 2.88; Figures 3A and 3B). To identify
the network sources of these predictions, we ordered all other
protein nodes by their Z score distance to EXP1 (Table S3): the
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Figure 4. CDNB and Hematin Are Substrates of EXP1
(A) Reaction kinetics and Michaelis-Menten analysis for WT EXP1 and R70T EXP1.
(B) Hematin inhibits the GST activity of EXP1 competitively (inset Dixon plot) with a Ki of 170 nM.
(C) Spectrometry-monitored kinetics of the spontaneous degradation of hematin (H) in GSH solution (H+G), EXP1-mediated enzymatic degradation of hematin
(G+H+E), and its inhibition after adding ART (10 nM, G+H+E+A).
(D) Michaelis-Menten analysis for EXP1-mediated degradation of hematin; curve (solid red line), least-square fits to Michaelis-Menten equation.
Data points represent mean values with standard error bars from three measurements.closest was a type 3 membrane GST from Saccharomyces
cerevisiae (with 10% sequence identity to EXP1), leading to the
prediction that EXP1 has a function akin to that of microsomal
glutathione S-transferases (MGSTs).
Guided by this prediction, we tested EXP1 in vitro for GST
activity, after purifying the full-length protein expressed in
Escherichia coli (Figures 3C and 3D). EXP1 was active in a deter-
gent-solubilized form, and standard GST assay spectrophoto-
metric measurements of EXP1 conjugating the thiol group of
glutathione toward the benzene ring of the cytotoxic benzene de-
rivative1-chloro-2,4-dinitrobenzene (CDNB) yieldeda specific ac-
tivity of 8.72 ± 3.73 nmol min1 mg1 (Figures 3E and S3C). This
activity of EXP1was comparable to that of the humanmicrosomal
GST (MGST1, Figures S3D–S3F) and the unrelated cytosolic
27 kDa GST from P. falciparum (PfGST, PF11_0187). Heterolo-
gous bacterial expression showed that no other P. falciparum
proteins were required for the observed activity of EXP1. This
GST activity of EXP1 establishes a new apicomplexan member
of the widespread superfamily of membrane-associated proteins
in eicosanoid and glutathione metabolism (MAPEG; Jakobsson
et al., 1999). No MAPEG members have previously been
described in the Plasmodium genus, although there is likeness in
quaternary structure:bothEXP1andeukaryoticMGST formmem-
brane homo-oligomers (Holm et al., 2006; Spielmann et al., 2006).
EXP1 Putative Catalytic Site
Even though EXP1 lacks substantial homology to other MGSTs,
there is a suggestive sequence identity, detected at 9% using
extended homology alignments (Simossis et al., 2005), and
global secondary structure similarity to a type 3 MGST from
the malaria mosquito vector Anopheles gambiae (GSTMIC3).
An Evolutionary Trace analysis (Mihalek et al., 2004) identified
Arg70 as well as the nearby Glu66 (Figure 3F) as being among
the most important residues in the MAPEG superfamily (top
8% of evolutionarily traced residue positions). Indeed, a substi-
tution of this arginine to a threonine is sufficient for a loss of
GST activity in leukotriene C4 synthase (Lam et al., 1997). We
therefore predicted that Arg70 in P. falciparum EXP1 might be
catalytically important for GST activity.To test this hypothesis, we expressed and purified an R70T
mutant of EXP1 (Figures S3E and S3F). Enzyme kinetics
confirmed that the reaction was approximately five times faster
for wild-type (WT) compared to the R70T mutant (Figure 4A)
and gave rate constants kcat = 34.27 s
1 for WT EXP1 and
kcat = 6.64 s
1 for R70T EXP1; the Michaelis-Menten constants
were KM = 1.20 mM and KM = 0.85 mM, respectively. Our data
suggest that R70 is important to the transferase mechanism
although not critically involved in substrate binding. WT EXP1 re-
action kinetics were in good agreement with other eukaryotic
MGSTs (Andersson et al., 1995).
Hematin Is an EXP1 Substrate
During malarial infection, the principal cytotoxic compound that
is released during parasite-mediated hemoglobin catabolism is
iron-bound heme, or its hydroxide, hematin. Given that hematin
weakly and uncompetitively inhibits PfGST through binding to a
preformed PfGST-GSH complex with a Ki value of 3 mM (Hiller
et al., 2006), we asked whether hematin might inhibit EXP1.
We found that inhibition was almost 20 times stronger, with
Ki = 170 nM, and was competitive (Figure 4B, inset)—i.e., hema-
tin competed with the substrate CDNB for binding to the EXP1
active site. As a control, spectrophotometry around 400 nm
showed that recombinant EXP1 purified from Escherichia coli
carried no detectable residual heme or hematin, and that only
the addition of exogenous hematin produced a prominent Soret
peak at 395 nm that is characteristic of hematin (Figure S4A).
This result opened the possibility that hematin itself is a substrate
of EXP1, which to our knowledge would be a unique property of
this malarial GST.
Reduced GSH spontaneously degrades heme by forming
a GSH-heme complex involving a nucleophillic attack in which
heme’s porphyrin ring is disrupted leading to the release of
Fe3+ (Atamna and Ginsburg, 1995). This process, which can be
spectrophotometrically monitored near 395 nm (Atamna and
Ginsburg, 1995; Ginsburg et al., 1998), has been proposed as
the underlying mechanism of GSH-mediated heme/hematin
degradation in P. falciparum-infected RBCs (Famin et al., 1999;
Ginsburg et al., 1998). We confirmed this reaction in vitro where,Cell 158, 916–928, August 14, 2014 ª2014 Elsevier Inc. 921
in the presence of reduced GSH, loss of free hematin was moni-
tored by a decrease of the Soret peak at 395 nm (Figures S4B
and S4C) and by mass spectrometry-based measurements of
the production of GSH-hematin complexes (Figures S4D–S4F).
Motivated by these observations, we asked whether the addition
of EXP1 enzymatically accelerates hematin degradation. Two
experiments demonstrate that EXP1 actively facilitates the
conjugation of reduced GSH to hematin. First, spectrophotom-
etry showed a 4-fold higher rate of decrease in 395 nm absor-
bance over the first 30 s of reaction time in the presence of
EXP1 (G+H+E), compared to the spontaneous degradation of
hematin (H+G, Figure 4C). Second,mass spectrometry identified
the GSH-hematin product in which addition of EXP1 increased
product yield over the spontaneous reaction >14-fold (Figures
S4G and S4H). A Michaelis-Menten analysis (Figure 4D)
measured kcat = 7.7 s
1 and a KM = 251 nM. Remarkably, the
high specificity constant kcat/KM 3 3 107 s1M1 placed
EXP1 near other exceptionally efficient enzymes such as fuma-
rase or catalase and thus not far from the universal diffusion limit
of108 s1M1. This activity toward hematin was unique among
all tested WT (SjGST, human MGST1) and mutant (R70T EXP1)
GSTs (Figure S4I).
In line with the functional formation of MGST homotrimers
(Holm et al., 2006), an inhibition analysis with R70T EXP1 (Fig-
ure S4J) indicated that several WT EXP1 units constitute one
functional catalytic unit. In addition, we bacterially expressed,
purified, and tested the function of the uncharacterized Plasmo-
dium yoelii EXP1 ortholog HEP17 (17 kDa hepatocyte erythro-
cyte protein). HEP17 shares only 44% sequence identity with
EXP1 such that, and consistent with the sequence logo in Fig-
ure 3F (inset), the proposed EXP1 catalytic residue R70 changes
to N in HEP17, and E66 changes to K. Despite this variation,
HEP17 matched the GST activity of EXP1 both toward CDNB
and toward hematin (Figures S4K and S4L). These data provide
evidence that hematin is a substrate of EXP1, which itself be-
longs to this Plasmodium family of membrane GSTs that share
hematin as a substrate.
ART Is a Potent Inhibitor of EXP1
Studies on artemisinin mode of action mostly agree that hemo-
globin uptake, digestion, and heme/hematin release lead to
cleavage of artemisinin’s endoperoxide bridge. The resulting
activated drug then causes oxidative damage to parasite mem-
branes (Klonis et al., 2011). EXP1 primarily localizes to the PVM,
and a construct of GFP fused to the EXP1 signal sequence has
been observed in spherical/cytostomal PVM invaginations that
appear to contain RBC cytosol and hemoglobin (Gru¨ring et al.,
2011). Endocytic vesicles have been reported to pinch off from
these invaginations to form acidified compartments during ring
stages, i.e., before the formation of a main food vacuole (FV)
(Abu Bakar et al., 2010). Using differential interference contrast
and immunofluorescence microscopy, our observations sug-
gested the presence of similar peripheral PVM invaginations
and vesicles, which in part colocalized with foci of EXP1 expres-
sion during trophozoite (Figure 5A) and late ring stages (Fig-
ure 5B). Such peripheral EXP1 foci were also observed in three
distinct parasite lines (ART-sensitive 3D7, ART-sensitive Dd2,
and ART-tolerant 3b1—see below and Experimental Proce-
dures), in two different drug-exposure conditions (with and922 Cell 158, 916–928, August 14, 2014 ª2014 Elsevier Inc.without ART), and at three different time points after RBC inva-
sion (12, 18, and 30 hr; Figures 5C, 5D, and S5A–S5D). These in-
vaginations and vesicles are potential sites of early hemoglobin
degradation and hematin release (Abu Bakar et al., 2010), which
could supply the peroxide bridge activator during ring stages
(Klonis et al., 2013b). Because of this temporal and spatial profile
of EXP1 expression, and the high affinity of EXP1 to its substrate
hematin (Figures 4B, 4D, and S4G), we hypothesized that ART
might inhibit hematin degradation catalyzed by EXP1. To test
this hypothesis in vitro, we added ART to our EXP1-hematin
reactions. These assays revealed competitive inhibition (Fig-
ure S5F) with a half-maximal inhibitory concentration (IC50)
of 2.05 nM (Figures 4C and 5E). Nonspecific inhibition was
excluded through stoichiometry controls (Habig et al., 2009):
after reducing enzyme concentration 10-fold, from 100 nM to
10 nM, potency changed by only 25% and remained within
error margins (Figure 5F). A control through liquid chromatog-
raphy-mass spectrometry (LC-MS) confirmed an ART-depen-
dent suppression of EXP1-mediated GSH-hematin adduct
formation down to spontaneous levels (Figure 5F, inset and
S5E). Consistent with the peroxide bridge activationmechanism,
the reaction displayed strong hematin dependence (Figure 5G):
inhibition of EXP1 activity toward CDNB, in the absence of
iron-bound hematin, was uncompetitive (Figure S5G) and 100-
fold less potent with an average IC50 of 184 nM. In a negative
control, we tested the standard cytosolic SjGST from Schisto-
soma japonicum, which showed 6-fold lower reaction velocities
that were close to the background noise level (Figures 5E and
S4I). Because EXP1 units form membrane homo-oligomers, we
further tested for cooperativity. A Hill equation analysis resulted
in a calculated IC50 value of 1.21 nM and in a Hill coefficient
nH = 0.56, which indicated lack of cooperativity: one EXP1 unit
appeared to bind one ART molecule (Figure 5G, inset). Our
results provide evidence of a potent, hematin-dependent inhibi-
tion of EXP1 activity by ART.
As a control for drug specificity, we tested the antimalarial
naphthoquinone atovaquone that targets the cytochrome bc1
complex in the mitochondrial electron transport chain (ETC)
(Fry and Pudney, 1992). Even though eukaryotic MGSTs have
a structural similarity with the ETC enzyme cytochrome
c oxidase (Holm et al., 2006), atovaquone did not inhibit
EXP1-mediated hematin degradation (Figure 5H). This suggests
that EXP1 may be targeted by endoperoxides but not by
naphthoquinones.
EXP1 in Parasite Drug Response
We then asked whether EXP1might be involved in drug action of
ART, whose cellular effectors may extend beyond the genes and
genomic regions that recent studies associated with emerging
ART resistance (Ariey et al., 2014; Cheeseman et al., 2012;
Park et al., 2012; Takala-Harrison et al., 2013). Specifically,
we tested a model (Mukanganyama et al., 2001) of reductive
metabolism of ART, mediated by a hypothetical GST that could
catalyze the formation of GSH-ART complexes via GSH binding
to the drug’s lactone ring to form a hydroperoxide moiety. We
addressed this model through EXP1 in the dihydroartemisinin-
pressured ART-tolerant parasite line 3b1 (see Experimental Pro-
cedures), compared to the parental line Dd2 and to the reference
drug-sensitive line 3D7.
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Figure 5. ART Is a Potent Inhibitor of EXP1
(A) Immunofluorescence microscopy of 3D7 trophozoite parasites labeled with anti-EXP1 antibodies (EXP1) shows evidence of peripheral expression of EXP1
that colocalizes with an apparent cytostomic invagination (C, red arrow; DIC panel). A fully formed trophozoite stage food vacuole (FV, green arrow) presents a
large accumulation of hemozoin, whereas small darker spots (yellow arrows) might be vesicles that have pinched off from the invagination.
(B) A late ring stage parasite displays a prominent spherical invagination that also partly corresponds to a convexly shaped EXP1 expression signal; small vesicles
(yellow arrow) may become components of an internal pre-FV compartment (dark irregular structure).
(C) Trophozoite stage 3D7 parasites exposed to ART indicate peripheral EXP1 expression (row C1) or enhanced expression foci at the PVM (row C2).
(D) Control trophozoites (DMSO) displayed similar morphology in EXP1 expression patterns to the drug-exposed parasites. Antibodies to the FV marker CRT
(P. falciparum chloroquine resistance marker) indicate that EXP1 expression was largely independent of FV location.
(E) ART inhibits EXP1 GST activity toward hematin.
(F) Stoichiometry control of ART-mediated inhibition of EXP1 activity toward hematin at a reduced enzyme concentration of 10 nM. Inset: ART-dependent
inhibition of GSH-hematin product formation.
(G) Inhibition of EXP1 activity toward CDNB through ART at three increasing CDNB concentrations. Inset: Hill equation analysis for inhibition of EXP1-mediated
hematin degradation through ART.
(H) Atovaquone does not inhibit EXP1 GST activity toward hematin. Dashed line represents fractional reaction velocity at zero concentration of atovaquone
(in absolute physical units 0.74 ± 0.06 mM min1).
Mean values and standard error bars from three experimental results.In vitro data from LC-MS showed that EXP1 can catalyze
the production of GSH-ART adducts in an ART concentra-
tion-dependent manner (Figure 6A). A control with SjGST,
which belongs to the same GST family as PfGST
(PF14_0187), yielded GSH-ART levels indistinguishable from
their spontaneous formation. These results recall earlier find-
ings that PfGST does not actively conjugate GSH to ART
and is unlikely to modulate parasite susceptibility to artemisi-nins (Deponte and Becker, 2005). LC-MS analysis with ex-
tracts of cultured parasites yielded GSH-ART levels that, in
ART-tolerant 3b1 parasites, were estimated to be 3.76 ±
0.31 times higher after ART exposure than the background
signal without drug challenge (Figures 6B and S6), whereas
in 3D7 parasites, those levels were low and almost indistin-
guishable from post-drug exposure levels (0.93 ± 0.09 ratio).
Similarly, in Dd2 parasites, GSH-ART measurements afterCell 158, 916–928, August 14, 2014 ª2014 Elsevier Inc. 923
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Figure 6. EXP1 Is Associated with ART Metabolism and Modulation of ART Susceptibility
(A) In vitro LC-MS of GSH-ART product formation (monitored at m/z 692.0) with increasing concentrations of ART.
(B) Abundance ratios of GSH-ART products from cultured parasite samples challenged with ART (ART+) against unchallenged parasites (ART); error bars
represent minimum and maximum ratios from two independent samples per condition. Significance levels *p < 0.05 and **p < 0.01 are from Student’s t test.
(C) Blood stage RNAmicroarray expression temporal profiles for exp1 and Pfgst at six time points between 8 and 48 hr post-RBC invasion. Shaded area indicates
late-ring/trophozoite transition.
(D) Distribution of transcript-level fold changes between the ART-resistant line 3b1 and the ART-sensitive line 3D7 from whole-genomemRNA expression arrays
over 5,446 P. falciparum genes (see Extended Experimental Procedures).
(E) Distribution of transcript-level fold changes between the ART-tolerant line 3b1 and the ART-sensitive line Dd2 (the parental line from which 3b1 was derived)
from whole-genome mRNA expression arrays over 5,446 P. falciparum genes (see Extended Experimental Procedures).
(F) Western immunoblotting shows evidence of elevated EXP1 levels in the ART-tolerant 3b1 line compared to Dd2 and 3D7. Loading controls employed
antibodies to the ER lumen protein-retaining receptor ERD2 (PF13_0280).ART challenge were only 1.52 ± 0.54 times higher than those
without drug exposure.
DNA sequencing of the exp1 locus, including 1.6 kb upstream
and 0.9 kb downstream of the coding region, revealed no differ-
ence between Dd2 and 3b1 (data not shown), and quantitative
PCR indicated no exp1 copy number change in 3b1 compared
to Dd2 (Extended Experimental Procedures). mRNA microarray
temporal profiles over six time points in the intra-erythrocytic
parasite stages showed the strongest transcriptional upregula-
tion of exp1 in line 3b1 near the late-ring/trophozoite transition
(Figure 6C), whereas this upregulation was less pronounced
in Dd2 by a factor of two. Relative to 3D7, exp1 mRNA levels
in 3b1 parasites were the third most highly upregulated among
all 5,446 genes tested (3.5-fold increase; p < 6 3 105; Fig-
ure 6C; Table S4; our unpublished data). In comparison to
Dd2, exp1mRNA levels in 3b1 were also upregulated by a factor924 Cell 158, 916–928, August 14, 2014 ª2014 Elsevier Inc.of 2.2 (p < 0.012; Figure 6D; Table S4). Remarkably, Pfgst
(PF14_0187) did not present higher transcript levels (expression
ratio 0.8 in 3b1/3D7 and 0.8 in 3b1/Dd2; Figures 6C–6E). To in-
crease microarray mRNA signal, 3b1 and Dd2 parasite samples
were pretreated with terminator exonuclease, and we note that
lower exp1 expression ratios were observed without this treat-
ment (expression ratio 1.3 in 3b1/3D7 and 1.2 in 3b1/Dd2).
EXP1 protein levels measured through immunoblotting with
EXP1 antibodies in parasites challenged for 6 hr with ART sug-
gested elevated expression in 3b1, followed by EXP1 levels in
the unchallenged line 3b1 (Figure 6F). This evidence of upregula-
tion was not observed in the control lines Dd2 and 3D7 (Fig-
ure 6F). Together, these results suggest that EXP1 is a GST
with ART as a substrate and support a model in which EXP1
may be part of a reductive metabolic pathway of ART by conju-
gating it to reduced glutathione.
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Figure 7. Model of EXP1 in the Asexual Intraerythrocytic
P. falciparum
EXP1 resides in homotrimeric complexes mainly in the PVM and inside cytos-
tomal invaginations of the PVM where, through GST activity, it may protect
membranes from hematin (ferriprotoporphyrin IX, Fp), which can be released
from internalized redbloodcell (RBC) cytosol andcatabolizedhemoglobin (Hb).
GSH-Fp complex formationmaybe an alternative to thedetoxification pathway
of Fp into hemozoin (Hz) through biomineralization, which eventually leads to
hemozoin (Hz) deposits in the food vacuole (FV). In the presence of heme/he-
matin, EXP1 activity can be potently inhibited by ART. EXP1 may also degrade
ART by conjugating it to reduced glutathione (GSH) in drug-tolerant parasites.DISCUSSION
Compression of supergenomic networksmay be the first positive
evidence to address the hypothesis that largebiological systems,
when represented through evolutionarily related information
sequences, are algorithmically compressible (Oexle, 1995). Crit-
ically, increased computational efficiency through compression
did not prove costly in terms of functional sensitivity and
accuracy: the malarial antigen EXP1 case study, in which the
network prediction preceded and guided the experimental
validation, illustrates the value of global network information.
The discovery of GST activity for EXP1, which we now also
refer to as PfMGST (P. falciparum membrane glutathione
S-transferase) and, for HEP17, PyMGST (Plasmodium yoelii
membrane glutathione S-transferase), points to EXP1 as being
a key component of glutathione metabolism in P. falciparum.
Heme/hematin release through hemoglobin degradation, and
separately antimalarial drug action, both confer strong oxidative
insults on the host cell and on the parasite (Becker et al., 2004).
Thus, relative to the classical hemozoin formation pathway,
EXP1-catalyzed hematin degradation may constitute a novel
GSH-mediated detoxification pathway within the malaria para-
site (Figure 7). Given that no other known essential protein activ-
ity or recently discussed drug target candidates (Cardi et al.,
2010; Chugh et al., 2013) are inhibited by ARTs at comparably
low concentrations, and the mounting but indirect evidence
that these drugs interfere with the glutathione-redox cycle
(O’Neill et al., 2010), we propose that EXP1 inhibition might be
an important component of the mode of action of ART.
A prominent feature of P. falciparum lines selected for resis-
tance to artemisinins appears to be ring-stage quiescence (Wit-
kowski et al., 2010): a temporary arrest of development andhemoglobin uptake and heme/hematin release until toxic ART
levels have been reduced sufficiently to resume growth (Klonis
et al., 2013a). Sensitive parasites appear to also be able to enter
the dormant stage, albeit at a reduced frequency compared
to in vitro-derived resistant lines, suggesting that resistant lines
have multiple means to withstand ART exposure (Teuscher
et al., 2012). Prior studies with ART-resistant P. yoelii parasites
have observed an upregulation of GSH-mediated detoxification
pathways (Witkowski et al., 2012). During ring-stage quiescence,
EXP1 might directly contribute to the degradation of ARTs by
conjugating them to reduced GSH, thus lowering the drugs’
oxidative potential and allowing a stronger parasite population
to recrudesce (Figure 7). Our data support further studies
on EXP1 and GSH-mediated oxidative stress responses in ART
action and P. falciparum susceptibility.
EXPERIMENTAL PROCEDURES
Supergenomic Network Data and Compressible Cliques
Large-scale protein network data came from the Search Tools for Interacting
Genes (STRING) database version 7.1. This had a total of 1.513 million protein
nodes of which 33% belonged to eukaryota, 63% to bacteria, and 4% to
archaea. Nodeswere connectedwith intrinsic evolutionary andwith contextual
species-specific links, including six types of protein-protein associations:
immunoprecipitation, yeast two-hybrid, coexpression, conserved genomic
neighborhood, phylogenetic co-occurrence, and literature co-occurrence.
Contextual links between nodes had weights given by a Bayes classifier of ev-
idence scores from STRING and normalized between 0 and 1, such that 1 indi-
cated the highest confidence in a functional association. In total, the network
had nc = 38,573,579 = 3.86 3 10
7 contextual links. Intrinsic links were binary:
1 indicated that two proteins were orthologs or that they were paralogs that
sharedorthology to a thirdprotein, and0 indicated that noevolutionary relation-
ship was detected. Orthology was established in a pair if its two protein
sequences had symmetrical best hits in sequence identity based on the
Smith-Waterman algorithm among all given lineages; mutually orthologous
proteins from at least three different species gave rise to COGs, which were
computed using the automated eggNOG algorithm (Jensen et al., 2008).
COGs were characterized asmaximal cliques (Mohseni-Zadeh et al., 2004). A
clique is maximal if it is not a subset of any other clique, and here we always
mean amaximal cliquewith ncog nodeswhen simply referring to a clique. Paral-
ogous genes from single species were grouped into single units (Jensen et al.,
2008), and COGs were maximal ncog-cliques when detected through best
reciprocal sequence hits or became so through mergers of maximal cliques
of ncog nodes that have (ncog1) nodes in common (Falls et al., 2004;Montague
andHutchison, 2000). Empirically (Mohseni-Zadeh et al., 2004), mergers affect
only a few (often less than 1%) of the originally detected cliques, which allowed
us directly to model COGs as maximal cliques in the sequence matching
network. The total number of intrinsic links within COGs is the sum of ncog
(ncog  1)/2 over all 33,929 COGs present in the network. This gave
540,563,390 z5.41 3 108 intra-COG links. Additionally, any pair of cliques
with significant sequence similarity results in at most ncog1 3 ncog2 inter-COG
links, and overall such pairs produced a maximum of niz1.93 3 10
11 links.
Cloning, Expression, and Purification of P. falciparum EXP1
The P. falciparum exp1 cDNAwas PCR amplified using the plasmid DNA clone
pHRPExGFP (kindly deposited by Dr. Kasturi Haldar at the Malaria Research
and Reference Reagent Resource Center, MR4, Manassas, VA, USA). The
recombinant exp1 product was sequence verified and cloned between NdeI
and HindIII restriction sites in the KanR pET28a (+) vector from Novagen
(New Canaan, CT, USA) to enable E. coli expression of N-terminal His-tagged
EXP1 protein (OL617, pET28a-His-EXP1). The EXP1 R70T mutant (OL618,
pET28a-His-EXP1-R70T) was generated using the QuikChange II XL Site-
Directed Mutagenesis Kit (Stratagene, La Jolla, CA, USA). The His-tagged
EXP1 WT and R70T proteins from the total lysate were purified using Ni-NTACell 158, 916–928, August 14, 2014 ª2014 Elsevier Inc. 925
agarose (QIAGEN, Valencia, CA, USA) affinity column chromatography.
Recombinant proteins were aliquoted and stored at 80C in GST assay
buffer (pH 7.3) containing 2% glycerol and 0.1% Triton X-100.
EXP1 GST Enzyme Assay
Purified EXP1 was preincubated in GST assay buffer (pH 6.5) with 0.1% Triton
X-100 and 2 mM reduced GSH on ice for 90 min, followed by the addition of
CDNB. Absorbance of the reaction was monitored at 340 nm, every 15 s for
a period of 10min. GST activity toward hematin was assayed by preincubating
100 nM WT protein with 0.1% Triton X-100, 2 mM GSH in pH 6.5 assay buffer
for 30 min on ice, followed by the addition of hematin to initiate hematin degra-
dation. Absorbance was monitored at 395 nm every second for 3 min.
EXP1 ART Inhibition Assay
ART and atovaquone were dissolved in 100% ethanol and added to 100 nM
WT EXP1 hematin reactions to determine hematin degradation inhibition.
WT EXP1 was preincubated in GST assay buffer (pH 6.5) with 0.1% Triton
X-100 and ART on ice for 30 min followed by the addition of 2 mM GSH and
hematin. The reaction was monitored at 395 nm every second for 3 min.
Generation of DHA/ART-Tolerant Parasites
3b1 parasites were selected from the Dd2 strain by culturing asexual blood
stage parasites (108 on average) in the presence of the artemisinin derivative
dihydroartemisinin (DHA) at sub-IC50 concentrations (2.8 nM, as compared to
a parental IC50 value of 6.4 nM) for 55 days, followed by progressive increases
in drug concentration (up to 28 nM) over the next 200 days. Acquired tolerance
to DHA and to ART was evidenced as an increased frequency of recrudes-
cence over a 30 day period following parasite exposure to high concentrations
of DHA/ART for 4 days (up to 112 nM; our unpublished data).
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